Publication | Closed Access

Targeted truncated TGF-β receptor type II delivery to fibrotic liver by PDGFβ receptor-binding peptide modification for improving the anti-fibrotic activity against hepatic fibrosis in vitro and in vivo

Translational MedicineFibrosisLiver FibrosisHepatologyMedicineLiver PhysiologyImmunologyHepatic FibrosisLiver DiseaseHepatology FibrosisAnti-fibrotic ActivityPharmacologyCirrhosis